| 25 May 2026 |
APAA (alpha-phenylacetoacetamide) CAS 102-01-2 |
6.8 |
1g |
1.0g |
-0.9% |
96.23% |
Lab F |
| 25 May 2026 |
Ivermectin |
7.7 |
10mg |
9.9mg |
-1.2% |
99.72% |
Lab G |
| 24 May 2026 |
AICAR |
6.7 |
20mg |
24.1mg |
+20.3% |
97.61% |
Lab B |
| 24 May 2026 |
Cardiogen |
7.6 |
20mg |
22.3mg |
+11.3% |
97.18% |
Lab G |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.7 |
5mg |
5.7mg |
+14.2% |
95.67% |
Lab C |
| 24 May 2026 |
HGH 191AA (Somatropin) |
8.2 |
30mg |
28.7mg |
-4.4% |
97.87% |
Lab F |
| 24 May 2026 |
Cabergoline |
4.4 |
100mg |
94.5mg |
-5.5% |
98.11% |
Lab E |
| 24 May 2026 |
N-Acetyl Epitalon Amidate |
10.0 |
2mg |
2.5mg |
+24.8% |
95.60% |
Lab C |
| 23 May 2026 |
Retatrutide |
8.0 |
30mg |
29.1mg |
-3.0% |
99.90% |
Lab E |
| 23 May 2026 |
Abaloparatide |
9.5 |
5mg |
5.5mg |
+9.6% |
97.91% |
Lab E |
| 23 May 2026 |
Testagen |
10.0 |
50mg |
56.1mg |
+12.1% |
99.68% |
Lab C |
| 23 May 2026 |
Vitamin D3 20000iu/ml |
8.9 |
100mg/ml |
105.9mg/ml |
+5.9% |
99.42% |
Lab A |
| 21 May 2026 |
Retatrutide |
6.7 |
10mg |
10.7mg |
+7.0% |
98.38% |
Lab E |
| 21 May 2026 |
EPO |
10.0 |
50mg |
48.4mg |
-3.2% |
99.82% |
Lab D |
| 21 May 2026 |
NandroMix 300 |
7.4 |
200mg/ml |
200.7mg/ml |
+0.3% |
99.17% |
Lab B |
| 21 May 2026 |
PEG MGF |
10.0 |
2mg |
1.7mg |
-13.3% |
98.36% |
Lab D |
| 20 May 2026 |
Retatrutide |
10.0 |
10mg |
10mg |
|
99.90% |
Lab E |
| 20 May 2026 |
Anadrol Oil |
6.2 |
300mg/ml |
293.0mg/ml |
-2.3% |
96.71% |
Lab G |
| 20 May 2026 |
BPC157 5mg + TB500 5mg Blend |
5.6 |
30mg |
31.0mg |
+3.3% |
96.92% |
Lab B |
| 20 May 2026 |
PTD-DBM |
8.3 |
20mg |
24.8mg |
+24.2% |
97.95% |
Lab E |
| 20 May 2026 |
TB-500 FRAG |
4.9 |
10mg |
10.4mg |
+3.7% |
96.32% |
Lab C |
| 20 May 2026 |
Test Enanthate |
6.3 |
300mg/ml |
321.8mg/ml |
+7.3% |
96.07% |
Lab F |
| 17 May 2026 |
Cartalax |
4.0 |
20mg |
22.3mg |
+11.4% |
98.37% |
Lab G |
| 29 Jan 2026 |
Retatrutide |
7.3 |
30mg |
30.6mg |
+2.0% |
99.61% |
Lab E |
| 29 Jan 2026 |
Semax |
8.0 |
30mg |
33.4mg |
+11.4% |
96.94% |
Lab A |
| 26 Jan 2026 |
Tirzepatide |
10.0 |
60mg |
61.6mg |
+2.7% |
99.90% |
Lab G |
| 26 Jan 2026 |
GW-501516 (Cardarine) |
8.1 |
25mg |
22.5mg |
-10.1% |
96.48% |
Lab G |
| 26 Jan 2026 |
Tirzepatide 30mg Pen Kit |
7.7 |
30mg |
36.2mg |
+20.7% |
99.28% |
Lab F |
| 15 Jan 2026 |
Retatrutide |
6.2 |
5mg |
4.99mg |
-0.2% |
99.09% |
Lab E |
| 9 Jan 2026 |
Botulinum toxin |
7.9 |
2mg |
1.7mg |
-13.3% |
96.77% |
Lab B |
| 9 Jan 2026 |
SLU-PP-332 250mcg + BAM15 50mcg Blend |
9.4 |
10mg |
10.8mg |
+8.5% |
99.15% |
Lab D |
| 6 Jan 2026 |
Lipo-C 120mg |
7.3 |
300mg/ml |
285.4mg/ml |
-4.9% |
95.18% |
Lab D |
| 12 Dec 2025 |
BMK ethyl glycidate CAS 41232-97-7 |
9.2 |
10g |
11.4g |
+14.2% |
97.36% |
Lab A |
| 12 Dec 2025 |
Dermorphin |
6.4 |
30mg |
28.4mg |
-5.2% |
96.53% |
Lab D |
| 12 Dec 2025 |
Ovagen |
6.3 |
50mg |
58.6mg |
+17.1% |
99.12% |
Lab B |
| 5 Dec 2025 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
10.0 |
10g |
8.5g |
-14.7% |
96.40% |
Lab G |
| 23 Nov 2025 |
Dianabol |
5.7 |
20mg |
21.7mg |
+8.5% |
98.29% |
Lab G |
| 23 Nov 2025 |
L-Carnitine 500mg |
7.0 |
250mg/ml |
239.2mg/ml |
-4.3% |
99.49% |
Lab A |
| 23 Nov 2025 |
Prednisone |
8.5 |
20mg |
21.8mg |
+9.0% |
97.73% |
Lab G |
| 18 Nov 2025 |
Tirzepatide |
7.4 |
30mg |
29.8mg |
-0.7% |
99.65% |
Lab E |
| 5 Nov 2025 |
Winstrol Oil (Stanozolol) |
5.7 |
300mg/ml |
322.5mg/ml |
+7.5% |
95.55% |
Lab C |
| 4 Nov 2025 |
Proviron (Mesterolone) |
4.0 |
20mg |
21.6mg |
+7.9% |
95.87% |
Lab E |
| 17 Oct 2025 |
ACE-031 |
7.9 |
10mg |
12.4mg |
+23.5% |
97.09% |
Lab B |
| 17 Oct 2025 |
Supertest 450 |
7.5 |
200mg/ml |
184.7mg/ml |
-7.6% |
98.12% |
Lab C |
| 3 Oct 2025 |
CJC-1295 With DAC |
7.2 |
2mg |
2.2mg |
+12.0% |
97.45% |
Lab E |
| 3 Oct 2025 |
MT-1 |
5.6 |
5mg |
5.7mg |
+13.2% |
98.51% |
Lab B |